Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> FOOD AND DRUG ADMINISTRATION Latest News

JUL 18, 2013 - Yahoo! News

A Must Read - Share

Celgene to stop blood cancer trial due to higher death rates

(Reuters) - Celgene Corp said it will stop a late-stage trial of its blood cancer drug Revlimid after it observed a higher number of deaths in patients taking the drug compared to those on a placebo. The trial was placed on a clinical hold by the U.S. Food and Drug Administration on July 12, Celgene said. The study was testing the drug in previously untreated, elderly patients with B-cell chronic lymphocytic leukemia. (Reporting by Esha Dey in Bangalore; Editing by Sreejiraj Eluvangal)

Tags: Celgene to stop blood cancer trial due to higher death rates,  Food And Drug Administration Latest News